Related Experiment Video

Updated: Aug 18, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Antigenotoxic potential of glucomannan on four model test systems

V Vlcková1, V Dúhová, S Svidová

  • 1Department of Genetics, Faculty of Natural Sciences, Comenius University, Bratislava, Slovak Republic. vlckova@fns.uniba.sk

Cell Biology and Toxicology
|May 4, 2005
PubMed

Insights

Glucomannan (GM) from Candida utilis demonstrates significant antimutagenic and anticlastogenic effects in various test systems. This natural polysaccharide shows promise as a protective agent against chemical mutagens.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Polysaccharides are known for their diverse biological activities.
  • Glucomannan (GM) is a polysaccharide with potential health benefits.
  • Evaluating the protective effects of natural compounds is crucial for developing new therapeutic agents.

Purpose of the Study:

  • To evaluate the antimutagenic, anticlastogenic, and bioprotective effects of glucomannan (GM) isolated from Candida utilis.
  • To assess GM's efficacy across four different model test systems.
  • To determine GM's potential as a natural protective agent against chemical mutagens.

Main Methods:

  • Assessing antimutagenic activity using Salmonella typhimurium strains TA97 and TA100 against 9-aminoacridine (9-AA) and sodium azide (NaN3).
  • Evaluating anticlastogenic effect against N-nitroso-N'-methylurea (NMU) induced chromosome aberrations in Vicia sativa.
  • Testing bioprotective effect in Chlamydomonas reinhardtii repair deficient strains (uvs10, uvs14) with methyl-methane-sulphonate (MMS).
  • Investigating antimutagenic potential against 4-nitro-quinoline-1-oxide (4-NQO) in Saccharomyces cerevisiae D7.

Main Results:

  • GM exhibited significant antimutagenic effects against 9-AA and NaN3 induced mutagenicity.
  • GM demonstrated anticlastogenic activity against NMU-induced chromosome aberrations.
  • GM showed bioprotective effects when co-treated with MMS in Chlamydomonas reinhardtii.
  • No statistically significant antimutagenic potential was observed against 4-NQO in Saccharomyces cerevisiae.

Conclusions:

  • Glucomannan (GM) from Candida utilis possesses notable antimutagenic, anticlastogenic, and bioprotective properties.
  • GM's efficacy varies depending on the mutagen and test system, potentially due to interactions with cell wall components like in Saccharomyces cerevisiae.
  • With its favorable properties (water solubility, low molecular weight), GM is a promising natural protective agent against chemical mutagens.

More Related Videos

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...